MICRONEEDLE PATCH AND PREPARATION METHOD THEREFOR

Abstract

A microneedle patch and a preparation method therefor are disclosed. The microneedle patch includes a base and a number of needles arranged on a surface of the base. The needles are dissolvable pointed bodies and contain a composition with cosmetic effects. The composition includes astaxanthin, hydrophilically modified resveratrol, collagen and hyaluromic acid. The method includes the steps of: pouring an aqueous solution of the composition into a mold; vacuumizing the mold; removing water therefrom; and demoulding the mold, thereby obtaining the microneedle patch. The present invention provides a variety of advantages including high safety, high stability, good absorption into the skin and obvious cosmetic effects.

Claims

1. A microneedle patch, comprising a base and a number of needles arranged on a surface of the base, wherein the needles are dissolvable pointed bodies, the needles containing a composition with cosmetic effects, the composition comprising astaxanthin, hydrophilically modified resveratrol, collagen and hyaluromic acid.

2. The microneedle patch according to claim 1, wherein the hydrophilically modified resveratrol is an inclusion compound formed by molecules of hydroxypropyl--cyclodextrin and resveratrol.

3. The microneedle patch according to claim 2, wherein a mass ratio of the resveratrol to the hydroxypropyl--cyclodextrin is (0.8-1.2):(9-12).

4. The microneedle patch according to claim 1, wherein weight parts of the components in the composition are as follows: Astaxanthin 0.05-0.3 parts; Hydrophilically modified resveratrol 0.1-0.3 parts; Collagen 1.5-5 parts; Hyaluromic acid 70-95 parts.

5. The microneedle patch according to claim 1, wherein the microneedle patch has a total height of 200 m to 500 m, the needles have a height of 30 m to 350 m, and the size at a widest point where the needles joint with the base is 100 m to 400 m.

6. The microneedle patch according to claim 1, wherein the needles are arranged on the surface of the base into an array, the array having a density of 50-300 needles per cm.sup.2.

7. The microneedle patch according to any one of claims 1 to 6, wherein the microneedle patch is used around the eyes or on the face, the cosmetic effects comprising anti-photoaging effects.

8. The microneedle patch according to claim 1, wherein the needles are cones, quadrangular pyramids or triangular pyramids.

9. A method of preparing a microneedle patch, comprising the steps of: obtaining hydrophilically modified resveratrol by adding a solution of resveratrol in ethanol to an aqueous solution of hydroxypropyl--cyclodextrin and homogeneously stirring, filtering and drying the mixture; forming an aqueous solution of a composition by successively adding hyaluromic acid, astaxanthin, the hydrophilically modified resveratrol and collagen to water and homogeneously stirring the mixture; and obtaining the microneedle patch by pouring the aqueous solution of the composition into a mold, vacuumizing the mold, removing water therefrom, and demoulding the mold.

10. The method according to claim 9, wherein a mass ratio of the resveratrol to the hydroxypropyl--cyclodextrin is (0.8-1.2):(9-12).

11. The method according to claim 9, wherein weight parts of the components in the composition are as follows: Astaxanthin 0.05-0.3 parts; Hydrophilically modified resveratrol 0.1-0.3 parts; Collagen 1.5-5 parts; Hyaluromic acid 70-95 parts.

12. The method according to claim 9, wherein the microneedle patch has a total height of 200 m to 500 m, the needles have a height of 30 m to 350 m, and the size at a widest point where the needles joint with the base is 100 m to 400 m.

13. The method according to claim 9, wherein the needles are cones, quadrangular pyramids or triangular pyramids.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0037] FIG. 1 is a schematic diagram showing the structure of microneedle patches prepared in Embodiments 1 to 3.

[0038] FIG. 2 shows the results of cytotoxicity tests performed on the microneedle patches in Embodiment 4.

[0039] FIG. 3 shows photos of an aluminum foil taken in a penetration ability test in Embodiment 5, in which a is a photo of a front side of the aluminum foil; b is a photo of a back side of the aluminum foil; c is a photo of the front side of the aluminum foil that has been penetrated by a microneedle patch; and d is a photo of the back side of the aluminum foil that has been penetrated by the microneedle patch.

[0040] FIG. 4 shows photos of fresh porcine skin taken in a penetration ability test in Embodiment 5, in which a is a photo of the fresh porcine skin; b is a photo of the porcine skin on which a microneedle patch is pressed; and c is a photo of the porcine skin after the microneedle patch is removed.

[0041] FIG. 5 shows a comparison between stability of hydrophilically modified resveratrol in a patch and that in an aqueous solution in Embodiment 6, in which a shows spectra of resveratrol in the patch at Day 0 and Day 7 measured on a UV spectrophotometer, and b shows spectra of resveratrol in the aqueous solution at Day 0 and Day 7 measured on a UV spectrophotometer.

[0042] FIG. 6 shows a comparison between stability of astaxanthin in a patch and that in an aqueous solution in Embodiment 6, in which a shows spectra of astaxanthin in the patch at Day 0 and Day 6 measured on a UV spectrophotometer, and b shows spectra of astaxanthin in the aqueous solution at Day 0 and Day 6 measured on a UV spectrophotometer.

[0043] FIG. 7 shows photos showing color comparisons between astaxanthin in a patch and astaxanthin in an aqueous solution in Embodiment 6, in which a shows a color comparison therebetween at Day 0, and b shows a color comparison therebetween at Day 6.

[0044] In these figures, [0045] 10-base; 20-needle.

DETAILED DESCRIPTION

[0046] For ease of understanding, the microneedle patch and the method of preparation thereof are described below by way of examples. It is to be understood that these examples are presented merely for the purpose of illustrating the present invention and not intended to limit the scope thereof in any sense.

[0047] The microneedle patch proposed in the present invention is generally used for anti-aging and cosmetic care of skin exposed to sunlight, such as face skin, skin around the eyes, neck skin, hand skin, etc., and may be designed in various shapes and sizes to meet different needs.

[0048] Unless otherwise specified, in the examples, all the raw materials and instruments used are commercially available conventional products, and all the technical means and processes employed are conventional means and processes.

EMBODIMENTS 1 TO 3

[0049] As shown in FIG. 1, as an example, the microneedle patch may be structured for use on skin around the eyes. It includes a base 10 and a plurality of needles 20 arranged into an array on a surface of the base 10. In this embodiment, the needles are solid cones. Of course, they may also be implemented as quadrangular pyramids, triangular pyramids or higher-order pyramids. Alternatively, they may be hollow pointed bodies.

[0050] The microneedle patch has a total height of 200-500 m, and the needles have a height of 30-350 m. The needles have a maximum extent of 100-400 m at their joints with the base (e.g., a diameter of bases in case of conical needles) and are arranged with a density of 50-300 needles/cm.sup.2. The total height of the microneedle patch refers to a straight-line distance from a bottom surface of the base to apices of the needles. The height of the needles refers to a distance measured between the bases and apices of the needles.

[0051] Dimensions of microneedle patches prepared in Embodiments 1 to 3 are summarized in Table 1.

TABLE-US-00001 TABLE 1 Diameter Total Height of of Bases Height Needles of needles Density (m) (m) (m) (needles/cm.sup.2) Embodiment 1 500 300 400 50 Embodiment 2 300 150 250 200 Embodiment 3 200 30 100 300

[0052] Each of the microneedle patches was prepared according to a method including the steps as follows.

[0053] 1) Prepare hydrophilically modified resveratrol. A proper amount of hydroxypropyl--cyclodextrin (a purchased mixture) was weight and dissolved in water, producing a solution with a concentration of 0.1 g/mL. 0.1 g of resveratrol was weight and dissolved in a proper amount of anhydrous ethanol. The solution was slowly added to the aqueous solution of cyclodextrin at 30 C. under magnetic stirring. A mass ratio of resveratrol to hydroxypropyl--cyclodextrin was controlled at (0.8-1.2):(9-12). After being stirred for 2 hours, the mixture was filtered to remove impurities and then freeze-dried. The product was resveratrol that had been modified to water-soluble. In the prepared hydrophilically modified resveratrol, molecules of hydroxypropyl--cyclodextrin and resveratrol formed an inclusion compound.

[0054] 2) Prepare a composition solution. Hyaluromic acid was dissolved in water, and stirred for about 0.5 hours, resulting in a clear, homogeneous solution. Astaxanthin, the hydrophilically modified resveratrol prepared in step 1) and collagen were successively added to the solution and homogenized therein by stirring. Astaxanthin, the hydrophilically modified resveratrol, collagen and hyaluromic acid were present at the following mass ratio:

TABLE-US-00002 Astaxanthin 0.05-0.3 parts Hydrophilically modified resveratrol 0.1-0.3 parts Collagen 1.5-5 parts Hyaluromic acid 70-95 parts

[0055] 3) Form the microneedle patch. The composition solution prepared in step 2) was poured into a microneedle mold, and the mold was then vacuumized and dried for removal of water. The microneedle patch was obtained after the mold was removed.

[0056] The mass ratios of the components and axial pressures per needle in the microneedle patches prepared in Embodiments 1 to 3 are presented in Table 2. As shown in Table 2, the microneedles exhibit high mechanical strength. The axial pressures per needle were measured by pressing needles with a flat pressure head and recording axial forces at different displacements. The flat pressure head has an effective area of 0.25 cm.sup.2 encompassing about 25 needles. The axial pressures per needle are calculated from recorded axial forces at a displacement of 0.2 mm

TABLE-US-00003 TABLE 2 Mass Ratio of Axial Resveratrol to Hydrophilically Pressure/ Hydroxypropyl- Modified Hyaluromic Needle -Cyclodextrin Astaxanthin Resveratrol Collagen Acid (N/0.2 mm) Embodiment 1 0.8:12 0.05 0.1 1.5 98.35 1.9 Embodiment 2 1.0:11 0.1 0.2 2 97.7 1.8 Embodiment 3 1.2:9 0.3 0.3 5 94.4 1.8

EMBODIMENT 4: CYTOTOXICITY

[0057] Cytotoxicity of a microneedle patch prepared in accordance with Embodiment 3 was tested.

[0058] The microneedle patch of Embodiment 3, which was 0.12-mm thick and weighed 400 mg, was dissolved in 4 mL of cell culture medium. Cytotoxicity of the microneedle patch was tested on mouse fibroblasts (L929 cells). As shown in FIG. 2, liquid culture medium of the same batch was used as a blank control, and a 14% DMSO solution as a positive control. The patch was the solution of the microneedle patch of Embodiment 3. The results show that the microneedle patch is completely non-toxic and can be safely used for absorption into the skin.

EMBODIMENT 5: PENETRATION ABILITY

[0059] A microneedle patch prepared in accordance with Embodiment 3 was cut into a round shape with a diameter of 1 cm and pressed on an aluminum foil for 30 s. The results were observed and recorded. As shown in FIG. 3, the aluminum foil was penetrated, demonstrating a certain level of mechanical strength of the mechanical strength of the anti-photoaging microneedle patch of the present invention.

[0060] A microneedle patch prepared in accordance with Embodiment 3 was dyed with methylene blue, cut into a round shape with a diameter of 1 cm, pressed for 40 s on fresh porcine skin that has been processed to remove subcutaneous fat therefrom, and then removed. As shown in FIG. 4, staining of the porcine skin was observed, and it was found after the removal of the microneedle patch that the porcine skin was penetrated, demonstrating that the microneedle patch of the present invention is mechanically strong enough to penetrate the skin.

EMBODIMENT 6: STABILITY

[0061] Astaxanthin and resveratrol are easily oxidized and are very unstable in water and in emulsions. Due to immiscibility of resveratrol with water, it was first hydrophilically modified, and its stability in patches and that in solutions was compared. The patches were made of astaxanthin and the hydrophilically modified resveratrol, and the solutions were aqueous solutions of astaxanthin and the hydrophilically modified resveratrol at the same concentrations. Compositions of the patches used in stability tests are shown in Table 3.

TABLE-US-00004 TABLE 3 Hydrophilically Components/Mass Modified Hyaluromic Ratio Astaxanthin Resveratrol Acid Patch Sample 1 0% 0.2% 99.8% Patch Sample 2 1% .sup.0% .sup.99%

[0062] As shown in FIG. 5, Patch Sample 1 was left at room temperature for 7 days without avoiding exposure to light, and the detection results of a UV spectrophotometer showed that there was no significant change between the content of resveratrol at the beginning and that after 7 days. In contrast, under the same conditions, the content of the hydrophilically modified resveratrol after 7 days was lower than that at the beginning. This indicates that the stability of the active ingredient resveratrol in Patch Sample 1 is superior over that in the aqueous solution.

[0063] As shown in FIG. 6, Patch Sample 2 was left at room temperature for 6 days without avoiding exposure to light, and the detection results of a UV spectrophotometer showed that there was no significant change between the content of astaxanthin at the beginning and that after 6 days. In contrast, under the same conditions, the content of astaxanthin after 6 days was significantly lower than that at the beginning. Moreover, as shown in FIG. 7, after being left at room temperature for 6 days, the color of astaxanthin in the solution became much lighter, while the color of astaxanthin in the patch did not show a significant change. This indicates that the stability of astaxanthin in Patch Sample 2 is superior over that in the aqueous solution.

[0064] At last, it is to be noted that the above embodiments are presented merely for the purpose of illustrating the subject matter of the present invention and are not intended to limit it in any sense. Although the present invention has been described in detail with reference to the foregoing embodiments, those of ordinary skill in the art will appreciate that modifications to the technical solutions provided in the embodiments or equivalents of part or all of the features thereof are still possible and such modifications or equivalents do not deviate the essence of the technical solutions from the scope of the various embodiments of the invention.